Tiny liner could stop aneurysm leaks after surgery

NCT ID NCT07020611

Recruiting now Disease control Sponsor: Life Seal Vascular Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This early study tests a new device called the Cygnum ASMD, which is placed inside the aneurysm during standard repair surgery. The goal is to see if it is safe and can prevent type II endoleaks—small leaks that can cause the aneurysm to grow again. Fifteen adults with large abdominal aortic aneurysms will be enrolled and followed with scans and checkups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cygnum Aneurysm Sac Management Device (ASMD)
What this could lead to: If it works, this device could reduce the need for follow-up procedures after aneurysm repair by preventing internal leaks.
What could go wrong: This is a very early, small trial (15 people) testing safety and feasibility only. The device may not work as hoped, and there are risks from the implant procedure itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABDOMINAL AORTIC ANEURYSM

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Auckland City Hospital
RECRUITING

Auckland, New Zealand

More trials for these conditions

Other studies related to the condition(s) this trial covers.